SCHEMBL5952994

SCHEMBL5952994

CCCCC1Cc2cc(Cc3ccccc3)c(Br)c(-c3ccc(OC)cc3)c2C1=O

nearest known ligand 0.38

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CYP24A1 Q07973 3/20 0.38
CYP27A1 Q02318 2/20 0.38
EDNRA P25101 1/20 0.36
ACHE P22303 2/20 0.35
LTA4H P09960 1/20 0.35
GPR55 Q9Y2T6 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 1/20 0.35
AADAT Q8N5Z0 1/20 0.35
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5951365 0.77 ACHE (0.34) ACHEAADAT
SCHEMBL2424817 0.67 METAP1 (0.65) CYP24A1CYP27A1ACHE
SCHEMBL29130764 0.64 METAP1 (0.64) CYP24A1CYP27A1
SCHEMBL11118779 0.63 GRM2 (0.47) ACHE
SCHEMBL1853465 0.61 ACHE (0.63) ACHE
SCHEMBL24169868 0.61 ACHE (0.39) ACHE
SCHEMBL5952036 0.60 METAP1 (0.37) ACHE
SCHEMBL5952908 0.60 ACHE (0.41) EDNRAACHE
SCHEMBL5952451 0.59 ACHE (0.39) ACHE
SCHEMBL29130805 0.59 METAP1 (0.68) CYP24A1CYP27A1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A CYP24A1 795/4885CYP27A1 375/4885EDNRA 2350/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 CYP24A1 708/4885CYP27A1 395/4885EDNRA 2351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.